Author: therawinformant

  • Why Kogan and these ASX shares just hit new record highs

    Chalk-drawn rocket shown blasting off into space

    Chalk-drawn rocket shown blasting off into spaceChalk-drawn rocket shown blasting off into space

    On Monday the S&P/ASX 200 Index (ASX: XJO) was on form and stormed almost 1.8% higher to hit a three-week high of 6,110.2 points.

    While this is positive, a number of shares on the local market are performing even better, and some have even been hitting record highs.

    Three that have achieved this feat are listed below. Here’s why they are flying high right now:

    Ansell Limited (ASX: ANN)

    The Ansell share price continued its ascent and hit a record high of $40.40 on Monday. The health and safety products company’s shares have been very strong performers this year thanks to increasing demand for its personal protective equipment during the pandemic. One broker that believes this increase in demand is structural and not a one off is Credit Suisse. For this reason, the broker put an outperform rating and $42.50 price target on its shares this week. This could mean that there’s still room for its share price to push higher.

    Kogan.com Ltd (ASX: KGN)

    The Kogan.com share price continued its remarkable run on Monday and stormed to a new record high of $20.77. Investors were fighting to get hold of the ecommerce company’s shares again yesterday after it revealed that its strong growth continued during July. According to the release, Kogan added an incremental 126,000 active customers during the month. This lifted its total active customers to a massive 2,309,000. Thanks to this strong customer growth and the continued shift to online shopping, Kogan reported a 110% increase in monthly gross sales and a 160% lift in gross profit for July.

    Mesoblast limited (ASX: MSB)

    The Mesoblast share price was on form again on Monday and hit a new record high of $4.88. The biotech company’s shares have been on fire this year thanks to excitement around its lead product candidate remestemcel-L. This excitement has been building since the recent release of its quarterly update. With the update, the company’s Chief Executive, Dr Silviu Itescu, commented: “Remestemcel-L has two imminent major milestones, the interim analysis in the ongoing Phase 3 trial of remestemcel-L in COVID-19 patients with acute respiratory distress syndrome and the FDA advisory committee panel review of our submission for potential approval of RYONCIL (remestemcel-L) in children with steroid-refractory acute graft versus host disease.” He added: “Together with the upcoming Phase 3 read-outs in chronic heart failure and back pain, these key milestones will take the Company into the most significant period in its history.”

    These stocks could rocket in a Post-COVID world (FREE STOCK REPORT)

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    In this FREE STOCK REPORT, Scott just revealed what he believes are the 3 ASX stocks for the post COVID world that investors should buy right now while they still can. These stocks are trading at dirt-cheap prices and Scott thinks these could really go gangbusters as we move into ‘the new normal’.

    *Returns as of 6/8/2020

    More reading

    James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of Kogan.com ltd. The Motley Fool Australia has recommended Ansell Ltd. and Kogan.com ltd. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post Why Kogan and these ASX shares just hit new record highs appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/2XNc2Br

  • Here’s what a stock split means for investors

    Plate with coloured wedges being parcelled out like a slice of pie representing a stock split

    Plate with coloured wedges being parcelled out like a slice of pie representing a stock splitPlate with coloured wedges being parcelled out like a slice of pie representing a stock split

    A stock split is a term that has recently been all over the investing world. Why? Well, because one of the largest companies in the world — Apple Inc. (NASDAQ: AAPL) — has recently announced a fresh stock split. So although companies on the ASX aren’t as prolific with stock splits as our friends over in the United States, understanding how these splits work is still a valuable piece of investor information that I think everyone should have their head around.

    What is a stock split?

    A stock split is… well, it’s all in the name. It refers to the process of a company deciding to ‘divide’ existing shares into smaller parts. Apple announced last week that it would be undergoing a 4-for-1 stock split soon. This means that an existing Apple share will be split into 4 parts, each worth a quarter of what the ‘unsplit’ shares are valued at.

    To be very clear, this has no impact on the value of a person’s Apple holdings. Say I have 2 Apple shares worth US$445 each before the split takes place. After the split, I will have 8 Apple shares worth approximately US$111.25 each. My overall Apple position has not changed one iota. It’s really just a game of arithmetic at the end of the day.

    Why do companies do it?

    Because a stock split has no real impact on any current or future investors, it can be hard to understand why a company would want to split their shares. The usual explanation is that it ‘levels the playing field’ of potential new investors to the company.

    If a company has a $5 share price, virtually anyone who can buy shares in the first place is able to invest in said company. But take a company like Amazon.com Inc. (NASDAQ: AMZN). Its shares are presently valued at more than US$3,000 (A$4,193) each. Many newer retail investors simply don’t have that kind of capital to sink into one company. One famous example is Warren Buffett’s Berkshire Hathaway Inc. (NYSE: BRK.A)(NYSE: BRK.B). It has never, in its long history, split its A-class shares. As a result, one single BRK.A share will set you back around US$315,000 today.

    The logic goes that those potential investors that might not have wanted to buy Apple for US$450 might be more inclined to do so if Apple shares were closer to US$110. And more buying pressure of any kind is good news for existing Apple shareholders.

    But in reality, I think stock splits make for good public relations and not much else. Something to remember when you next hear the term ‘stock split’!

    5 stocks under $5

    We hear it over and over from investors, “I wish I had bought Altium or Afterpay when they were first recommended by The Motley Fool. I’d be sitting on a gold mine!” And it’s true.

    And while Altium and Afterpay have had a good run, we think these 5 other stocks are screaming buys. And you can buy them now for less than $5 a share!

    *Extreme Opportunities returns as of June 5th 2020

    More reading

    John Mackey, CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool’s board of directors. Sebastian Bowen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of and recommends Amazon, Apple, and Berkshire Hathaway (B shares) and recommends the following options: long January 2021 $200 calls on Berkshire Hathaway (B shares), short January 2021 $200 puts on Berkshire Hathaway (B shares), short January 2022 $1940 calls on Amazon, long January 2022 $1920 calls on Amazon, and short September 2020 $200 calls on Berkshire Hathaway (B shares). The Motley Fool Australia has recommended Amazon, Apple, and Berkshire Hathaway (B shares). We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post Here’s what a stock split means for investors appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/2PMYykJ

  • A2 Milk Company share price on watch after naming its new CEO

    A2M share price

    A2M share priceA2M share price

    The A2 Milk Company Ltd (ASX: A2M) share price will be on watch today after the infant formula and fresh milk company finally found its next permanent managing director and chief executive officer.

    What did a2 Milk Company announce?

    In December last year, former CEO Jayne Hrdlicka abruptly left the fast-growing company after she “agreed to step down” from her role with immediate effect. Ms Hrdlicka was replaced with its former CEO, Geoffrey Babidge, on an interim basis while the company searched globally for a permanent replacement.

    This morning a2 Milk Company revealed that it has finally found its next leader, with the appointment of David Bortolussi. He will succeed interim CEO Geoffrey Babidge early in the 2021 calendar year.

    Who is David Bortolussi?

    Mr Bortolussi was most recently the Group President – International Innerwear, at HanesBrands, where he was responsible for and had extensive exposure to Asian sourcing markets, particularly in China. This includes various brand distribution partnerships in the region.

    Prior to this, Mr Bortolussi spent five years at Foster’s Group, where he held the role of Chief Strategy Officer and was responsible for corporate strategy, M&A, business development, and performance improvement. In this role, he led the operational separation and demerger of the domestic beer and global wine businesses, generating significant shareholder value.

    Given the hefty cash balance that a2 Milk Company is sitting on at the moment, the new CEO’s experience in M&A could come in very handy in the near future.

    The company’s chair, David Hearn, commented: “Following an extensive global search, the Board is delighted to have secured David for this role. David has demonstrated significant skill in guiding businesses through periods of significant growth whilst also effectively managing the changes that expansion frequently requires.”

    “The a2 Milk Company is going through a period of continued strong growth in dynamic markets and David’s skillset and comprehensive strategic and operational experience will serve the company well. I am looking forward to working with David as we navigate these challenges together with the board and management team,” he added.

    The new CEO appears up for the challenge. Mr Bortolussi said: “I have always admired The a2 Milk Company’s achievements and I am looking forward to joining the board and management team to continue the development of such an extraordinary business. The team at a2 has created a very distinctive consumer proposition, amazing brand and strong culture with so much potential. I’m thrilled to have the opportunity to lead such a talented and experienced team, and to be part of the next phase of growth.”

    These stocks could rocket in a Post-COVID world (FREE STOCK REPORT)

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    In this FREE STOCK REPORT, Scott just revealed what he believes are the 3 ASX stocks for the post COVID world that investors should buy right now while they still can. These stocks are trading at dirt-cheap prices and Scott thinks these could really go gangbusters as we move into ‘the new normal’.

    *Returns as of 6/8/2020

    More reading

    Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of A2 Milk. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post A2 Milk Company share price on watch after naming its new CEO appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/2XPagjj

  • Where is the Bega Cheese share price headed in August?

    Question mark made up of banknotes in front of blue background

    Question mark made up of banknotes in front of blue backgroundQuestion mark made up of banknotes in front of blue background

    The Bega Cheese Ltd (ASX: BGA) share price jumped 2.0% higher yesterday as the S&P/ASX 200 Index (ASX: XJO) got off to a strong start.

    The Bega Cheese share price is now up 6.5% in 2020 but where is it headed in August?

    Why 2020 has been a good year for Bega

    For one thing, supply costs are remaining low. Farmgate milk prices remain depressed, which is good for Bega’s profit margins.

    There’s also been strong demand for Bega’s products in the first half of 2020. Bega operates in the Consumer Staples sector, which is good for earnings stability.

    Strong supermarket sales have certainly helped and I’m hoping for solid earnings across Bega’s spreads, dairy consumer packaged goods, nutritionals and dairy ingredients.

    Demand from China was somewhat subdued in Bega’s half-year result in February but I think it still represents a strong growth corridor.

    Where will the Bega Cheese share price go in August?

    The Bega Cheese share price will be worth watching in August.

    The Aussie dairy group hasn’t provided an exact date for its full-year results announcement but reported last year’s result on 28 August 2019.

    Slowing sales to China is a potential area of concern for Bega. However, if the August full-year result indicates steady demand, I think Bega’s shares may continue to climb in 2020.

    The other potential headwind is an increasing number of homebrand products. These brands from the likes of Coles Group Ltd (ASX: COL) are putting pressure on both volume and pricing for Bega.

    That’s why I think the August full-year result is one to watch. It could be the key to understanding where the Bega Cheese share price is set to end the year.

    Foolish takeaway

    The Bega Cheese share price has been a strong performer in 2020 and the full-year result looms as the key for further gains.

    I’d want to see steady earnings and a solid growth outlook, particularly for Asia.

    Bega shares currently trade at a price-to-earnings ratio of 64.2, which is a bit on the high side. That means I won’t be buying until I see the company’s latest financials later this month.

    These 3 stocks could be the next big movers in 2020

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    In this FREE STOCK REPORT, Scott just revealed what he believes are the 3 ASX stocks for the post COVID world that investors should buy right now while they still can. These stocks are trading at dirt-cheap prices and Scott thinks these could really go gangbusters as we move into ‘the new normal’.

    *Returns as of 6/8/2020

    More reading

    Motley Fool contributor Ken Hall has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of COLESGROUP DEF SET. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post Where is the Bega Cheese share price headed in August? appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/2PD6uoK

  • Is the Origin Energy share price cheap or will it keep falling?

    Power lines with a sunset in the background

    Power lines with a sunset in the backgroundPower lines with a sunset in the background

    The Origin Energy Ltd (ASX: ORG) share price jumped 1.4% higher yesterday in a good sign for investors. However, the Origin Energy share price remains down 31.2% for the year.

    So, is the ASX energy share in the buy zone or will it fall further in 2020?

    Why the Origin Energy share price has slumped this year

    It’s been tough going for ASX energy shares in 2020. That means Origin Energy is in good company when it comes to the ASX losers list.

    One of the big factors has been a slump in demand for energy. That’s largely been driven by the coronavirus pandemic, which has shut down operations in many energy-intensive industries like travel and manufacturing.

    Origin has a number of different operating segments. The company is involved in energy sales, renewable energy, gas exploration and production as well as power generation. 

    The recent slump in demand has naturally impacted on realised prices and earnings for Origin. That means all eyes will be on Origin’s full-year results announcement on Thursday 20 August.

    What can we expect from Origin’s full-year result?

    I don’t think anyone would be surprised by a drop in Origin’s full-year earnings and profit numbers. Despite the Origin Energy share price trading with a dividend yield of 5.2%, I’d expect that to fall lower.

    The real question is just how badly earnings have been impacted and what the outlook for FY21 is like.

    Investors are naturally interested in what the future looks like. That means a clear pathway for dividends and more certainty around management’s strategy for the short- to medium-term.

    There has been an uptick in renewable energy usage during 2020. As one of the largest energy producers in Australia, Origin is well-placed to capitalise on any changing consumer trends.

    Is Origin in the buy zone?

    The Origin share price currently trades at a price-to-earnings (P/E) ratio of 10.1. That’s slightly cheaper than rival AGL Energy Limited (ASX: AGL) and could make it a good relative buy.

    The 31.2% share price drop this year is a concern, but could mean it has been oversold. If we see a clear growth strategy and signs of strengthening earnings, I think the Origin Energy share price could be in the buy zone this month.

    These 3 stocks could be the next big movers in 2020

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    In this FREE STOCK REPORT, Scott just revealed what he believes are the 3 ASX stocks for the post COVID world that investors should buy right now while they still can. These stocks are trading at dirt-cheap prices and Scott thinks these could really go gangbusters as we move into ‘the new normal’.

    *Returns as of 6/8/2020

    More reading

    Motley Fool contributor Ken Hall has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post Is the Origin Energy share price cheap or will it keep falling? appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/30KEG8r

  • Moderna (MRNA): 5-Star Analyst Joins the COVID-19 Vaccine Pricing Debate

    Moderna (MRNA): 5-Star Analyst Joins the COVID-19 Vaccine Pricing DebateThe narrative surrounding COVID-19-focused pharma companies is developing a new tone. While none of the players involved in the race to bring a vaccine to market have reached the final regulatory hurdles just yet, progress is being made with several Phase 3 trials already taking place.The talk is now centered around the issue of pricing – how much each company plans to sell its vaccine for.On the clinical trial front, mRNA vaccine maker Moderna (MRNA) is among the pack’s leaders. A Phase 3 clinical trial for mRNA-1273, its COVID-19 vaccine candidate, kicked off last week and data should be published before the year is over, or best-case scenario, by as early as October.Moderna has several small volume agreements in place to supply $400 million-worth of the potential vaccine, which price the vaccine in the $32-$37 range. Per a recent presentation, Moderna implied it values the vaccination at roughly $300 per course. So, this pricing is far lower than what Moderna would like to sell mRNA-1273 for.However, given the current climate and the public’s desperate need for a vaccine taken into account, Chardan analyst Geulah Livshits believes the pricing plan “would place Moderna towards the top end among other recently-announced government agreements.”For 100 million doses, BNTX/Pfizer’s candidate is priced at $1.95 billion, Johnson & Johnson’s at $1 billion, Sanofi/GSK’s at $2.1 billion, and Novavax’s at $1.6 billion. AstraZeneca’s candidate is priced at $1.2 billion for 300 million doses. So, at the bottom end of Moderna’s pricing plan, mRNA-1273 would cost $3.2 billion per 100 million doses.For Livshits, the implications of such a premium are clear.“We believe it might be challenging for Moderna to negotiate higher pricing relative to other players given what have thus far been (to us) overall similar clinical and preclinical profiles, and therefore see a high likelihood of pricing large-volume contracts in the mid-high teens per dose range," the 5-star analyst said.All in all, Livshits keeps her Buy rating on MRNA as is, while the price target stays put too. At $95, the upside potential is 32%. (To watch Livshits’ track record, click here)Among Livshits’ colleagues, Moderna remains a popular pick. MRNA's Strong Buy consensus rating is based on 12 Buys and 3 Holds. The average price target is only a touch below the Chardan analyst’s, and at $93.67, could provide gains in the shape of 30% in the year ahead. (See Moderna stock analysis on TipRanks)To find good ideas for healthcare stocks trading at attractive valuations, visit TipRanks’ Best Stocks to Buy, a newly launched tool that unites all of TipRanks’ equity insights.Disclaimer: The opinions expressed in this article are solely those of the featured analyst. The content is intended to be used for informational purposes only. It is very important to do your own analysis before making any investment.

    from Yahoo Finance https://ift.tt/2Fbuspg

  • $765M Kodak loan halted as deal under regulatory scrutiny

    $765M Kodak loan halted as deal under regulatory scrutiny  Eastman Kodak’s $765 million dollar deal was halted after a report from the Wall Street Journal sparked an SEC investigation into how the company disclosed the deal with the government to the public. Yahoo Finance’s The Final Round panel discuss the details of the probe and what will happen to Kodak’s deal.

    from Yahoo Finance https://ift.tt/33Q1RzZ

  • Here’s How Much Investing $1,000 In Berkshire Hathaway Stock In 2010 Would Be Worth Today

    Here's How Much Investing $1,000 In Berkshire Hathaway Stock In 2010 Would Be Worth TodayInvestors who owned stocks in the 2010s generally experienced some big gains. In fact, the SPDR S&P 500's (NYSE: SPY) total return for the decade was 250.5%. But there's no question some big-name stocks did much better than others along the way.Berkshire's Difficult Decade: One underperformer of the last decade was Warren Buffett's Berkshire Hathaway Inc. (NYSE: BRK-A) (NYSE: BRK-B).Berkshire struggled throughout the past decade to keep pace with a bull market that was led by high-growth, high-valuation tech stocks. Buffett is one of the most iconic value investors of all time, but value stocks have underperformed in a climate of historically low interest rates and skyrocketing corporate debt.One of Buffett's best moves of the past 10 years was his decision to go all-in on Apple, Inc (NASDAQ: AAPL) in May 2016. At the time, Apple shares were trading at around $110 per share. Roughly five years later, Apple is now trading at $444 and it's by far Berkshire's largest holding, worth around $111.5 billion.But Buffett also had plenty of missteps in the past decade as well. Buffett invested in airline stocks in 2016 only to sell them all in early 2020 near the market bottom during the COVID-19 sell-off.Berkshire's Class B shares started the 2010s trading at around $70 after a 50-to-1 stock split in early 2010. Berkshire hit its decade low of $65.35 in late 2011. Berkshire shares then began a steady march higher over the next three years, peaking at $152.94 in late 2014.From there, Berkshire spent most of the next two years trading sideways in a wide range of between $125 and $150. The stock finally broke out to the upside in late 2016.2020 And Beyond: Berkshire ultimately peaked at $231.61 in early 2020, its high point of the last 10 years. However, Berkshire shares were hammered in early 2020 during the broad market COVID-19 sell-off, and the stock dropped to as low as $159.50, its lowest point since 2017. While the stock has since rebounded to around $210, it has still delivered underwhelming overall performance over the past 10 years.In fact, $1,000 worth of Berkshire stock in 2010 would be worth about $2,614 today, assuming reinvested dividends.Looking ahead, analysts expect Berkshire's climb to resume in the coming months. The average price target among the three analysts covering the stock is $223.45, suggesting 6.7% upside from current levels.President Barack Obama meets with Warren Buffett in the Oval Office in 2011. Official White House Photo by Pete Souza.See more from Benzinga * Why Warren Buffett May Have Changed His Tune On Berkshire Buybacks * Exclusive: Genius Brands CEO Sees Profitability 'By The End Of The Year'(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

    from Yahoo Finance https://ift.tt/3acF9TT

  • 3 exciting ASX growth shares to buy with $3,000

    business leader making money

    business leader making moneybusiness leader making money

    Are you interested in adding some growth shares to your portfolio? Then I think the three named below could be great options.

    I feel all three are well-positioned to deliver above-average earnings growth over the next few years, which could lead to them generating strong returns for investors.

    Here’s why I would invest $3,000 across the three:

    Bravura Solutions Ltd (ASX: BVS)

    The first ASX growth share to consider investing some of these funds into is Bravura Solutions. It is a financial technology company responsible for the Sonata wealth management platform. This popular wealth management platform allows advisers to connect and engage with clients via computers, tablets, or smartphones. Demand for the platform has been growing very strongly in the past few years and has underpinned strong earnings growth. The good news is that demand shows no signs of slowing. And combined with recent acquisitions that have given Bravura access to new and lucrative markets, I believe this means it is well-positioned to grow its earnings at a solid rate over the coming years.

    PolyNovo Ltd (ASX: PNV)

    Another growth share to consider buying with these funds is PolyNovo. It is a medical device company which I think could be a great long term option due to its NovoSorb Biodegradable Temporising Matrix (BTM) product. This exciting product was developed at CSIRO and is used as a wound dressing to treat full-thickness wounds and burns. It currently has a sizeable $1.5 billion market opportunity, but management plans to extend its use into the hernia and breast treatment markets. If this is successful, it could be very lucrative for the company. It estimates that these markets would add an extra $6 billion to its addressable market.

    Pushpay Holdings Ltd (ASX: PPH)

    A third growth share that I would invest $1,000 of these funds into is Pushpay. This donor management platform provider has been benefiting greatly from the shift to a cashless society and the digitisation of the church. Adoption of its industry leading platform has been increasing rapidly in recent years, leading to Pushpay’s revenue and operating earnings growing at an explosive rate. The good news is that Pushpay still has a very long runway for growth and is aiming to win a 50% share of the medium and large church market. If it achieves this, it will have captured a US$1 billion revenue opportunity. This compares to the US$127.5 million operating revenue it recorded in FY 2020.

    Man who said buy Kogan shares at $3.63 says buy these 3 ASX stocks now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    In this FREE STOCK REPORT, Scott just revealed what he believes are the 3 ASX stocks for the post COVID world that investors should buy right now while they still can. These stocks are trading at dirt-cheap prices and Scott thinks these could really go gangbusters as we move into ‘the new normal’.

    *Returns as of 6/8/2020

    More reading

    James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of POLYNOVO FPO and PUSHPAY FPO NZX. The Motley Fool Australia owns shares of and has recommended Bravura Solutions Ltd. The Motley Fool Australia has recommended PUSHPAY FPO NZX. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post 3 exciting ASX growth shares to buy with $3,000 appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/33KCsI3

  • 5 things to watch on the ASX 200 on Tuesday

    On Monday the S&P/ASX 200 Index (ASX: XJO) started the week on a very positive note. The benchmark index stormed almost 1.8% higher to 6,110.2 points.

    Will the market be able to build on this on Tuesday? Here are five things to watch:

    ASX 200 expected to edge higher.

    The ASX 200 is poised to edge higher on Tuesday after a positive night of trade on Wall Street. According to the latest SPI futures, the ASX 200 is set to open the day 1 point higher. Over in the United States, the Dow Jones jumped 1.3%, the S&P 500 rose 0.3%, and the Nasdaq index fell 0.4%.

    A2 Milk Company names new CEO.

    The A2 Milk Company Ltd (ASX: A2M) share price will be on watch today after naming its new managing director and chief executive officer. The infant formula and fresh milk company has appointed David Bortolussi. He will succeed interim CEO Geoffrey Babidge early in the 2021 calendar year. Mr Bortolussi was previously the Group President – International Innerwear, at HanesBrands.

    Challenger results.

    The Challenger Ltd (ASX: CGF) share price could be on the move today when it releases its full year results. The annuities company has provided guidance for normalised net profit before tax at the bottom end of the range of $500 million and $550 million in FY 2020. This compares to $548 million in FY 2019. All eyes will be on its guidance for FY 2021.

    Oil prices rebound.

    Energy producers such as Beach Energy Ltd (ASX: BPT) and Woodside Petroleum Limited (ASX: WPL) could be on the rise today after oil prices rebounded. According to Bloomberg, the WTI crude oil price is up 2% to US$41.96 a barrel and the Brent crude oil price has risen 1.2% to US$44.94 a barrel. Strong Chinese factory data and U.S. stimulus hopes supported oil prices.

    Gold price higher.

    Gold miners including Evolution Mining Ltd (ASX: EVN) and Newcrest Mining Limited (ASX: NCM) will be on watch today after the gold price pushed higher. According to CNBC, the spot gold price has risen 0.4% to US$2,036.4 an ounce amid hopes of major U.S. stimulus.

    Man who said buy Kogan shares at $3.63 says buy these 3 ASX stocks now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    In this FREE STOCK REPORT, Scott just revealed what he believes are the 3 ASX stocks for the post COVID world that investors should buy right now while they still can. These stocks are trading at dirt-cheap prices and Scott thinks these could really go gangbusters as we move into ‘the new normal’.

    *Returns as of 6/8/2020

    More reading

    Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Challenger Limited. The Motley Fool Australia owns shares of A2 Milk. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post 5 things to watch on the ASX 200 on Tuesday appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/3kzms1i